Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junping Shi

Showing results (131-140 of 178) with videos related to

Pageof 18
Sort By:
Oncology Reports|April 3, 2020
Characterization of genomic alterations and the significance of PI3K/mTOR pathway mutations and tumor mutational burden in non‑small cell lung cancerJing Hu, Yanhong Shang, Xiaoliang Shi, et al.
BMC Infectious Diseases|October 23, 2023
Biliary sepsis complication with congenital hepatic fibrosis: an unexpected outcomeJiawei Sun, Xiaoxiao Mi, Xiaoying Ye, et al.
American Journal of Translational Research|June 21, 2019
Berberine prevents non-alcoholic steatohepatitis-derived hepatocellular carcinoma by inhibiting inflammation and angiogenesis in miceYan Luo, Guoyan Tian, Zhenjie Zhuang, et al.
Journal of Advanced Research|August 24, 2025
Application of machine learning and deep learning in metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysisHuan Zhang, Xiangyu Wu, Wenjing Ni, et al.
Obesity (Silver Spring, Md.)|January 25, 2021
Fecal Fungi Dysbiosis in Nonalcoholic Fatty Liver DiseaseNingning You, Jiali Xu, Liyan Wang, et al.
Journal of Gastrointestinal Oncology|January 24, 2022
Specific genomic alterations and prognostic analysis of perihilar cholangiocarcinoma and distal cholangiocarcinomaYuanwen Zheng, Yejun Qin, Wei Gong, et al.
Chinese Medical Journal|August 5, 2025
Bidirectional crosstalk of the gut-liver axis in metabolic dysfunction-associated steatotic liver diseaseJuan Zhang, Xin Tong, Wei Lin, et al.
Gut|September 8, 2017
Fatty acids promote fatty liver disease via the dysregulation of 3-mercaptopyruvate sulfurtransferase/hydrogen sulfide pathwayMeng Li, Chengfu Xu, Junping Shi, et al.
The Journal of Infectious Diseases|May 15, 2026
Single-cell RNA sequencing reveals mucosal BPIFA1-high-expressing neutrophils aid immune defense in SARS-CoV-2 breakthrough infectionXue Bai, Shixing Chen, Shengxia Yin, et al.
Hepatology International|January 22, 2024
The impact of an increased Fibrosis-4 index and the severity of hepatic steatosis on mortality in individuals living with diabetesXiaoyan Ma, Yixuan Zhu, Yee Hui Yeo, et al.
Pageof 18

Showing results (131-140 of 178) with videos related to

Sort By:
Pageof 18
Oncology Reports|April 3, 2020
Characterization of genomic alterations and the significance of PI3K/mTOR pathway mutations and tumor mutational burden in non‑small cell lung cancerJing Hu, Yanhong Shang, Xiaoliang Shi, et al.
BMC Infectious Diseases|October 23, 2023
Biliary sepsis complication with congenital hepatic fibrosis: an unexpected outcomeJiawei Sun, Xiaoxiao Mi, Xiaoying Ye, et al.
American Journal of Translational Research|June 21, 2019
Berberine prevents non-alcoholic steatohepatitis-derived hepatocellular carcinoma by inhibiting inflammation and angiogenesis in miceYan Luo, Guoyan Tian, Zhenjie Zhuang, et al.
Journal of Advanced Research|August 24, 2025
Application of machine learning and deep learning in metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysisHuan Zhang, Xiangyu Wu, Wenjing Ni, et al.
Obesity (Silver Spring, Md.)|January 25, 2021
Fecal Fungi Dysbiosis in Nonalcoholic Fatty Liver DiseaseNingning You, Jiali Xu, Liyan Wang, et al.
Journal of Gastrointestinal Oncology|January 24, 2022
Specific genomic alterations and prognostic analysis of perihilar cholangiocarcinoma and distal cholangiocarcinomaYuanwen Zheng, Yejun Qin, Wei Gong, et al.
Chinese Medical Journal|August 5, 2025
Bidirectional crosstalk of the gut-liver axis in metabolic dysfunction-associated steatotic liver diseaseJuan Zhang, Xin Tong, Wei Lin, et al.
Gut|September 8, 2017
Fatty acids promote fatty liver disease via the dysregulation of 3-mercaptopyruvate sulfurtransferase/hydrogen sulfide pathwayMeng Li, Chengfu Xu, Junping Shi, et al.
The Journal of Infectious Diseases|May 15, 2026
Single-cell RNA sequencing reveals mucosal BPIFA1-high-expressing neutrophils aid immune defense in SARS-CoV-2 breakthrough infectionXue Bai, Shixing Chen, Shengxia Yin, et al.
Hepatology International|January 22, 2024
The impact of an increased Fibrosis-4 index and the severity of hepatic steatosis on mortality in individuals living with diabetesXiaoyan Ma, Yixuan Zhu, Yee Hui Yeo, et al.
Pageof 18